1. Home
  2. MACI vs DRTS Comparison

MACI vs DRTS Comparison

Compare MACI & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MACI
  • DRTS
  • Stock Information
  • Founded
  • MACI 2024
  • DRTS 2015
  • Country
  • MACI United States
  • DRTS Israel
  • Employees
  • MACI N/A
  • DRTS N/A
  • Industry
  • MACI
  • DRTS Medical/Dental Instruments
  • Sector
  • MACI
  • DRTS Health Care
  • Exchange
  • MACI NYSE
  • DRTS Nasdaq
  • Market Cap
  • MACI 221.6M
  • DRTS 211.7M
  • IPO Year
  • MACI 2024
  • DRTS N/A
  • Fundamental
  • Price
  • MACI $10.28
  • DRTS $2.57
  • Analyst Decision
  • MACI
  • DRTS Strong Buy
  • Analyst Count
  • MACI 0
  • DRTS 2
  • Target Price
  • MACI N/A
  • DRTS $8.00
  • AVG Volume (30 Days)
  • MACI 15.0K
  • DRTS 28.0K
  • Earning Date
  • MACI 01-01-0001
  • DRTS 05-19-2025
  • Dividend Yield
  • MACI N/A
  • DRTS N/A
  • EPS Growth
  • MACI N/A
  • DRTS N/A
  • EPS
  • MACI N/A
  • DRTS N/A
  • Revenue
  • MACI N/A
  • DRTS N/A
  • Revenue This Year
  • MACI N/A
  • DRTS N/A
  • Revenue Next Year
  • MACI N/A
  • DRTS N/A
  • P/E Ratio
  • MACI $44.00
  • DRTS N/A
  • Revenue Growth
  • MACI N/A
  • DRTS N/A
  • 52 Week Low
  • MACI $9.95
  • DRTS $1.75
  • 52 Week High
  • MACI $10.35
  • DRTS $4.39
  • Technical
  • Relative Strength Index (RSI)
  • MACI N/A
  • DRTS 46.76
  • Support Level
  • MACI N/A
  • DRTS $2.52
  • Resistance Level
  • MACI N/A
  • DRTS $2.61
  • Average True Range (ATR)
  • MACI 0.00
  • DRTS 0.11
  • MACD
  • MACI 0.00
  • DRTS 0.02
  • Stochastic Oscillator
  • MACI 0.00
  • DRTS 87.10

About MACI MELAR ACQUISITION CORP. I

Melar Acquisition Corp I is a blank check company.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.

Share on Social Networks: